Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - alanin, arginin, asparaginsyre, dinatriumphosphatdodecahydrat, glutaminsyre, glycin, histidin, isoleucin, kaliumacetat, leucin, lysinhydrochlorid, magnesiumchloridhexahydrat, methionin, natriumacetattrihydrat, natriumhydroxid, phenylalanin, prolin, serin, threonin, tryptophan, tyrosin, valin - infusionsvæske, opløsning

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - alanin, arginin, asparaginsyre, glutaminsyre, glycin, histidin, isoleucin, leucin, lysinacetat, lysinmonohydrat, methionin, phenylalanin, prolin, serin, threonin, tryptophan, tyrosin, valin - infusionsvæske, opløsning

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - acetylcystein, alanin, arginin, asparaginsyre, glutaminsyre, glycin, histidin, isoleucin, leucin, lysinmonohydrat, methionin, n-acetyltyrosin, phenylalanin, prolin, serin, taurin, threonin, tryptophan, valin - infusionsvæske, opløsning

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pharmsure veterinary products europe ltd - mycoplasma synoviae stamme ms-h - immunologicals for aves, live bakterielle vacciner - kylling - til aktiv immunisering af fremtidige slagtekyllinger, kyllinger fra fremtidige lagdeltagere og fremtidige lagkyllinger for at reducere lungerne og reducere antallet af æg med unormal skaldannelse forårsaget af mycoplasma synoviae.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

elanco gmbh - mycoplasma hyopneumoniae, stamme p-5722-3 (inaktiveret) - injektionsvæske, emulsion - 6000 ru/dosis - svin

Den Europæiske Union - dansk - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svin - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - gentamicinsulfat - infusionsvæske, opløsning - 3 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bayer ab - moxifloxacinhydrochlorid - infusionsvæske, opløsning - 1,6 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

abcur ab - clindamycinphosphat - injektions-/infusionsvæske, opløsning - 150 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

navamedic asa - clindamycinphosphat - infusionsvæske, opløsning - 300 mg